Oncopeptides AB (LTS:0RN4) Net Intangibles Purchase And Sale : kr0.00 Mil (TTM As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Oncopeptides AB Net Intangibles Purchase And Sale?

Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

Oncopeptides AB's net Intangibles purchase and sale for the three months ended in Mar. 2025 was kr0.00 Mil. Its net Intangibles purchase and sale for the trailing twelve months (TTM) ended in Mar. 2025 was kr0.00 Mil.

Oncopeptides AB Net Intangibles Purchase And Sale Historical Data

The historical data trend for Oncopeptides AB's Net Intangibles Purchase And Sale can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncopeptides AB Net Intangibles Purchase And Sale Chart

Oncopeptides AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Intangibles Purchase And Sale

Get a 7-Day Free Trial

Oncopeptides AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Net Intangibles Purchase And Sale	Get a 7-Day Free Trial															-	-	-	-	-

Oncopeptides AB Net Intangibles Purchase And Sale Calculation

Net Intangibles Purchase And Sale for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

Oncopeptides AB Net Intangibles Purchase And Sale Related Terms

Thank you for viewing the detailed overview of Oncopeptides AB's Net Intangibles Purchase And Sale provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncopeptides AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncopeptides AB (LTS:0RN4) » Definitions » Net Intangibles Purchase And Sale

Comparable Companies

Traded in Other Exchanges

ONCO:Sweden OND:Germany

Address

Luntmakargatan 46, Stockholm, SWE, SE-111 37

Website

https://www.oncopeptides.com

Oncopeptides AB is a biotech company focused on the research, development, and commercialization of therapies for difficult-to-treat hematological diseases. The company uses its proprietary Peptide Drug Conjugate (PDC) to develop compounds that rapidly and selectively deliver cytotoxic agents into cancer cells. It has focused on the development of the product candidate Melflufen (Pepaxti), a peptide-conjugated alkylator, belonging to a new class of drugs called Peptidase Enhanced Compounds. Melflufen is intended as an effective treatment for hematological cancers and, in particular, multiple myeloma.

Oncopeptides AB Headlines

No Headlines